📰 Booster Molecule News

Booster Molecule News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Booster Molecule. Real-time updates on events, politics, business and more.

Poseida Therapeutics Announces Virtual 2024 Annual Meeting Of Stockholders

June 3, 2024

SAN DIEGO, June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX ), a clinical-stage allogeneic cell therapy and genetic medi

Poseida Therapeutics Inc Annual Meeting Poseida Therapeutics Specific Gene Editing System Booster Molecule

Source: menafn.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

May 2, 2024

- Leverages Poseidas proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ -- Astellas...

Xyphos Biosciences Astellas Pharma Kristin Yarema Naoki Okamura Adam Pearson Astellas Company

Source: marketscreener.com

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma

April 8, 2024

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...

San Diego United States Syed Rizvi Rajesh Belani Bhagirathbhai Dholaria Poseida Therapeutics Inc

Source: prnewswire.com

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 1, 2024

SAN DIEGO, April 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases,...

Syed Rizvi Compensation Committee Poseida Therapeutics Inc Poseida Therapeutics Chief Medical Nasdaq Listing Rule